Type 2 Diabetes
Conditions
Interventions
None listed
Sponsors
National Center for Global Health and Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Japanese Type 2 diabetic atient with at least one encounter in the database between April 1, 2017 and March 31, 2019
Exclusion criteria
Exclusion criteria: Patients with type 1 diabetes and any secondary diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To describe the prevalence and co-prevalence of comorbid conditions among patients with T2DM. These conditions include congestive heart failure, chronic kidney disease, retinopathy, neuropathy, cardiovascular disease (coronary artery disease, cerebrovascular disease, and peripheral arterial disease), pancreatitis, liver disease, hypertension, hyperlipidemia, overweight/obesity, amputation, bone fracture, periodontal disease and neoplasm. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the prevalence of the comorbidities stratified by age (<65 years, 65-74 years, >=75 years), gender and duration of T2DM (tertiles). | — |
Countries
Japan
Contacts
Public ContactMitsuru Ohsugi
Research Institute, National Center for Global Health and Medicine Diabetes and Metabolism Information Center
Outcome results
None listed